Researchers at the University of Basel have released RNAmel, an open-source R/Shiny platform that combines a clickable bulk ...
An open-source AI research workbench with 23 built-in Skills, 525 marketplace Skills, 36 research connectors, and four agent ...
A new web-based platform called TurbOmics lets researchers integrate metabolomics, proteomics, and transcriptomics data using advanced statistical methods without any programming skills.
Explore role of Excel in biological research & why structured spreadsheet training matters for data quality, research ...
QIAGEN supports TB control through both education and diagnostic testing. Its activities include the annual Global TB Clinical and Educational Summit and QuantiFERON-TB Gold Plus (QFT-Plus), a ...
Portable, relocatable R distributions for Windows built from the R installers: CRAN's for x64, and the builds listed under Available Versions for ARM64. No installation required. Extract and run. An R ...
Human milk (HM) composition is variable to support changing infant needs and is influenced by maternal diet and health. We harmonized HM data from three randomized trials in Burkina Faso (MISAME-III), ...
Computational biology and bioinformatics is an interdisciplinary field that develops and applies computational methods to analyse large collections of biological data, such as genetic sequences, cell ...
QIAGEN is also introducing the QIAGEN Discovery Platform, which enables the integration of AI with QIAGEN’s biomedical knowledge base and molecular data to support drug discovery. The platform is ...
Genomics is the study of the full genetic complement of an organism (the genome). It employs recombinant DNA, DNA sequencing methods, and bioinformatics to sequence, assemble, and analyse the ...
Final Results for the year ended 30 June 2026 and Notice of AGM. Physiomics plc (AIM: PYC), a leading mathematical ...
Triton International Ltd. 8% Perp. Pfd. Series B-0.35% Triton International Ltd. 7.375% Cum. Redeem. Perp. Pfd. Series C-0.81% Triton International Ltd. 6.875% Perp. Pfd. Series D-0.68% ...